NasdaqGS:JAZZPharmaceuticals
Is Jazz Pharmaceuticals (JAZZ) Still Attractive After A 47% One Year Share Price Rally
Considering whether Jazz Pharmaceuticals at around US$182.69 is still offering value after a strong run, or if you might be late to the story.
The stock has returned 0.2% over the last 7 days, 5.5% year to date, and 47.2% over the past year, with a 3.9% decline over 30 days and a 25.6% return over 3 years, as well as 10.9% over 5 years.
Recent attention around Jazz Pharmaceuticals has focused on its role within the broader pharmaceuticals and biotech space and how its product portfolio...